News from acelrx pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 17, 2021, 08:30 ET AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Plastic Surgery Procedures

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Jan 20, 2021, 09:00 ET AcelRx Announces Pricing of $27.5 Million Public Offering of Common Stock

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Jan 19, 2021, 16:01 ET AcelRx Announces Underwritten Public Offering of Common Stock

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Jan 19, 2021, 08:30 ET AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Jan 14, 2021, 08:30 ET AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Dec 10, 2020, 09:00 ET AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Dec 10, 2020, 08:30 ET AcelRx Announces $10 Million Registered Direct Common Stock Offering

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Dec 09, 2020, 12:20 ET AcelRx Pharmaceuticals to Present at LD Micro Main Event

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Dec 04, 2020, 08:30 ET AcelRx Pharmaceuticals Announces Partnership with the National Rural Health Association

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 18, 2020, 08:30 ET AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 06, 2020, 13:29 ET AcelRx Pharmaceuticals to Present at Credit Suisse 29th Annual Virtual Healthcare Conference

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 05, 2020, 16:05 ET AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Oct 29, 2020, 16:05 ET AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release third quarter financial results ...

Sep 29, 2020, 08:30 ET AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA®

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Sep 22, 2020, 08:30 ET AcelRx Awarded U.S. Army Contract for DSUVIA®

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Sep 14, 2020, 08:30 ET AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Sep 10, 2020, 16:05 ET AcelRx Pharmaceuticals to Present at Two Upcoming Conferences

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 24, 2020, 08:30 ET AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Aug 19, 2020, 08:30 ET AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 10, 2020, 16:01 ET AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Aug 03, 2020, 16:05 ET AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release second quarter financial...

Jul 23, 2020, 08:40 ET AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA®

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced an agreement to market DSUVIA®, a sublingual opioid...

Jul 23, 2020, 08:30 ET AcelRx Announces $10 Million Common Stock Offering Priced At The Market

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Jun 03, 2020, 18:50 ET AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase

AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Jun 01, 2020, 20:00 ET AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...